Signaturefd, LLC Insmed Inc Transaction History

Signaturefd, LLC

$5.4 Billion
Q2 2025

A detailed history of Signaturefd, LLC transactions in Insmed Inc stock. As of the latest transaction made, Signaturefd, LLC holds 535 shares of INSM stock, worth $55,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares

535

Previous 867 38.29%

Holding current value

$55,062

Previous $66,000 19.7%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$64.81 - $105.9 $21,516 - $35,158	-332 Reduced 38.29%	535 $53,000
Q1 2025 May 01, 2025	BUY	$65.25 - $83.83 $21,206 - $27,244	325 Added 59.96%	867 $66,000
Q4 2024 Feb 10, 2025	BUY	$66.29 - $76.63 $6,562 - $7,586	99 Added 22.35%	542 $37,000
Q3 2024 Oct 21, 2024	BUY	$62.0 - $79.01 $6,448 - $8,217	104 Added 30.68%	443 $32,000
Q2 2024 Jul 29, 2024	BUY	$22.0 - $69.71 $1,078 - $3,415	49 Added 16.9%	339 $22,000
Q1 2024 May 03, 2024	SELL	$25.72 - $29.94 $360 - $419	-14 Reduced 4.61%	290 $7,000
Q4 2023 Jan 31, 2024	BUY	$23.42 - $31.74 $3,068 - $4,157	131 Added 75.72%	304 $9,000
Q2 2023 Aug 01, 2023	BUY	$16.44 - $21.1 $2,268 - $2,911	138 Added 394.29%	173 $3,000
Q1 2023 Apr 28, 2023	BUY	$16.26 - $21.73 $569 - $760	35 New	35 $0
Q3 2022 Nov 08, 2022	BUY	$20.88 - $28.21 $2,255 - $3,046	108 Added 1542.86%	115 $2,000
Q2 2022 Aug 10, 2022	SELL	$17.07 - $25.71 $631 - $951	-37 Reduced 84.09%	7 $0
Q1 2022 May 02, 2022	BUY	$20.42 - $28.13 $898 - $1,237	44 New	44 $1,000
Q3 2020 Nov 03, 2020	SELL	$26.0 - $34.5 $1,118 - $1,483	-43 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$14.11 - $29.42 $606 - $1,265	43 New	43 $1,000
Q1 2020 Apr 23, 2020	SELL	$13.63 - $33.98 $1,880 - $4,689	-138 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$16.12 - $24.98 $2,224 - $3,447	138 New	138 $3,000

Others Institutions Holding INSM

# of Institutions

497

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.9B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account